Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Despite strategic initiatives and potential growth opportunities, the earnings call reveals significant challenges: a 31% revenue decrease YoY, declining gross margins, and liquidity concerns with reduced cash reserves. These outweigh the positive aspects like new customer acquisitions and revenue projections. The lack of a shareholder return plan further dampens sentiment. The Q&A section did not provide substantial positive insights to alter this outlook. Overall, the financial health and market strategy weaknesses suggest a negative stock price movement in the near term.
Revenue $2.6 million, reflecting a 31% decrease year-over-year due to the loss of a customer at the beginning of the current year.
Revenue per health plan enrolled member per month Approximately $449, a decrease from $462 in Q2 2024 and from $552 in Q3 2023, primarily due to a mix shift from newer customers with different pricing structures and the inclusion of new Engage members with lower revenue per member.
Membership data Added 1,166 new members during the quarter, compared to 881 in Q2 2024 and 1,272 in Q3 2023, resulting in a 64% enrollment rate, up from 61% in Q2 2024 and 50% in Q3 2023, due to higher enrollment rates from new customers.
Gross margin 62%, a decrease from 65.6% in Q2 2024 and 72% in Q3 2023, with expectations of maintaining current levels but potential slight decreases during new customer expansions.
Operating cash flow Negative $1.4 million, an improvement from negative $1.8 million in the same quarter last year and negative $4.5 million in Q2 2024.
Cash reserves $8 million, a decrease from $9.7 million at the end of the previous year.
Annual revenue from current customers under contract Approximately $11 million to $13 million, including a 20% increase from the recent expansion.
Potential additional annual revenue from opportunities at the bottom of the funnel Approximately $9 million to $12 million, representing a 75% to 100% increase from current customers under contract.
Engage Solution Expansion: Ontrak has expanded its Engage solution to approximately 20,000 members of Sentara Health Plans, including a Specialized Care Coaching Program for members with rising health risks.
WholeHealth+ Expansion: Ontrak has secured two new regional health plan customers and four health plan expansions since January, showcasing the versatility of its offerings including WholeHealth+ and Engage.
Quality Solutions Launch: A new health plan customer in the Northeast has approved the expansion of services to include Ontrak’s quality solutions to help close over 30,000 HEDIS gaps in care.
Pipeline Growth: Ontrak's pipeline includes four active prospects in late-stage sales, representing significant growth opportunities, including a healthcare system with 80,000 Medicare Advantage lives.
Market Demand Trends: Macro trends such as elevated medical costs in Medicaid plans and the emphasis on quality metrics like HEDIS scores are driving demand for Ontrak's services.
Membership Growth: Ontrak added 1,166 new members in Q3, resulting in a net increase of 313 members, with a 64% enrollment rate.
Gross Margin: Q3 gross margin was 62%, a decrease from previous quarters, with expectations of maintaining current levels.
Strategic Partnerships: Ontrak is progressing with partnerships with two new customers and two expansions, indicating a strong focus on strategic growth and innovation.
Financial Outlook: For Q4 2024, Ontrak anticipates revenues between $2.9 million and $3.2 million, reflecting a sequential increase.
Revenue Decline: In Q3, Ontrak's revenue decreased by 31% compared to the same period last year, primarily due to the loss of a customer at the beginning of the year.
Membership Changes: The company experienced a decrease in revenue per health plan enrolled member, averaging approximately $449, down from $552 in Q3 of 2023, attributed to a mix shift from newer customers with different pricing structures.
Operational Challenges: The gross margin decreased to 62% from 72% in Q3 of last year, with expectations of slight decreases during new customer expansions due to proactive hiring of member-facing employees.
Cash Flow Issues: Operating cash flow for Q3 was negative $1.4 million, although this was an improvement from negative $1.8 million in the same quarter last year.
Economic Factors: Medicaid plans are facing elevated medical cost trends and funding challenges post-pandemic, which may impact Ontrak's customer base and revenue.
Regulatory Risks: The company is navigating the fallout of redeterminations in Medicaid, which could affect member engagement and retention.
Customer Expansion: Ontrak has secured two new regional health plan customers and four health plan expansions since January 2024, expanding offerings across Medicaid, HARP, Commercial, and Marketplace.
Engage Solution: The Engage solution is being offered to approximately 20,000 planned members of Sentara Health Plans, including a Specialized Care Coaching Program for members with rising health risks.
HEDIS Gap Closure: Ontrak is focusing on closing HEDIS measure gaps for health plan partners, achieving a greater than 50% outreach success rate.
Pipeline Growth: The company has four active prospects in late-stage sales, representing significant growth opportunities.
New Customer Prospects: One new customer prospect is a healthcare system with 80,000 Medicare Advantage lives, and another is a large Blues plan with over 400,000 Medicaid lives.
Revenue Expectations: For Q4 2024, Ontrak anticipates revenues in the range of $2.9 million to $3.2 million, representing a 12% to 23% sequential increase.
Annual Revenue Projections: Current customers under contract are expected to generate approximately $11 million to $13 million in annual revenue, with additional opportunities representing $9 million to $12 million.
Gross Margin Outlook: Gross margin is expected to maintain current levels, with potential slight decreases during new customer expansions.
Membership Growth: The company added 1,166 new members in Q3 2024, with a 64% enrollment rate, and anticipates continued growth.
Shareholder Return Plan: None
Despite enrollment growth and strategic initiatives, the company faces significant challenges: a 25% YoY revenue decrease, reduced gross margins, and ongoing cash flow issues. The positive aspects, such as NCQA certification and potential revenue growth, are overshadowed by reliance on new contracts and financial strain. The lack of significant Q&A insights further supports a negative outlook. Overall, the negatives outweigh the positives, suggesting a potential stock price decline of 2% to 8%.
Despite strong operational updates and strategic initiatives, the significant EPS miss and anticipated revenue decline raise concerns. While new partnerships and expansions are promising, the lack of immediate financial impact and unclear management responses add uncertainty. The absence of a share buyback program and potential regulatory and competitive risks further dampen sentiment. Given these factors, the stock price is likely to experience a negative movement.
The company faces significant challenges, including a notable revenue decline and cash flow issues. Despite some positive developments like new partnerships and customer acquisitions, the guidance indicates a substantial revenue drop in Q1 2025. Additionally, the lack of a share buyback program and high disenrollment rates further contribute to a negative outlook. The absence of analyst sentiment from the Q&A section does not offset these concerns.
Despite strategic initiatives and potential growth opportunities, the earnings call reveals significant challenges: a 31% revenue decrease YoY, declining gross margins, and liquidity concerns with reduced cash reserves. These outweigh the positive aspects like new customer acquisitions and revenue projections. The lack of a shareholder return plan further dampens sentiment. The Q&A section did not provide substantial positive insights to alter this outlook. Overall, the financial health and market strategy weaknesses suggest a negative stock price movement in the near term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.